Skip to main content
. 2018 May 25;9(40):25946–25956. doi: 10.18632/oncotarget.25408

Figure 4. Kaplan-Meier analysis of breast cancer specific survival showing the impact of low (grey line) and high (black line) GPER protein expression.

Figure 4

within the cytoplasm in patients who did not receive endocrine therapy (A) or patients that did receive endocrine therapy (B) with significance determined using the log-rank test. The numbers shown below the Kaplan-Meier survival curves are the number of patients at risk at the specified month.